Hepatitis C in adults and adolescents with hemophilia: A randomized, controlled trial of interferon alfa-2b and ribavirin

Fried, 1999, Management of hepatitis C in the hemophilia patient, Am J Med, 107, 85S, 10.1016/S0002-9343(99)00391-5 Brettler, 1990, Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients, Blood, 76, 254, 10.1182/blood.V76.1.254.254 Eyster, 1994, Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study, Blood, 84, 1020, 10.1182/blood.V84.4.1020.1020 Kumar, 1993, Serologic markers of viral hepatitis A, B, C, and D in patients with hemophilia, J Med Virol, 41, 205, 10.1002/jmv.1890410307 Eyster, 1999, Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study, J Infect Dis, 179, 1062, 10.1086/314708 Lethagen, 2001, Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease, Br J Haematol, 113, 87, 10.1046/j.1365-2141.2001.02700.x Tradati, 1998, A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers, Blood, 91, 1173 Preston, 1995, Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease, Blood, 85, 1259, 10.1182/blood.V85.5.1259.bloodjournal8551259 Rumi, 1997, A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers, Blood, 89, 3529 Yoshikawa, 1995, Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan, J Gastroenterol, 30, 367, 10.1007/BF02347513 Bresters, 1992, Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients, Scand J Gastroenterol, 27, 166, 10.3109/00365529208999943 Ko, 2001, Interferon-alpha treatment of chronic hepatitis C in children with hemophilia, J Pediatr Gastroenterol Nutr, 32, 41, 10.1097/00005176-200101000-00013 Poynard, 1998, Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT), Lancet, 352, 1426, 10.1016/S0140-6736(98)07124-4 McHutchison, 1999, Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C, Semin Liver Dis, 19, 57 McHutchison, 1998, Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group, N Engl J Med, 339, 1485, 10.1056/NEJM199811193392101 Sauleda, 2000, Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C, Thromb Haemost, 83, 807, 10.1055/s-0037-1613924 Santagostino, 2002, Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy, Blood, 99, 1089, 10.1182/blood.V99.3.1089 Manns, 2001, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, Lancet, 358, 958, 10.1016/S0140-6736(01)06102-5 Fried MW Shiffman ML Reddy KR Smith C Marinos G Goncales FL Haussinger D Combination of peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection Blanchette, 1991, Hepatitis C infection in children with hemophilia A and B, Blood, 78, 285, 10.1182/blood.V78.2.285.285 Kanesaki, 1993, Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction, J Pediatr, 123, 381, 10.1016/S0022-3476(05)81736-6 McHutchison, 2000, Hepatitis C, 203, 10.1016/S1874-5326(00)80015-0 Kanazawa, 1994, Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients, Hepatology, 20, 1121, 10.1002/hep.1840200504 Okada, 1992, The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients, Hepatology, 16, 619, 10.1002/hep.1840160302 Wong, 1997, The role for liver biopsy in haemophiliacs infected with the hepatitis C virus, Br J Haematol, 97, 343, 10.1046/j.1365-2141.1997.452691.x